PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will: • rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets; • monitor the emergence of a synthetic opioid market as seen in North America; • identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal. https://health-family.force.com/s/Welcome